CHOP Commits $50 Million To Gene Therapy Spin-Out Spark Therapeutics
This article was originally published in The Pink Sheet Daily
Executive Summary
Non-profit hospital spins out its first start-up, which will house one program to address a heritable form of blindness, another to treat hemophilia B.